PI
MYGN icon

PineBridge Investments’s Myriad Genetics MYGN Stock Holding History

PineBridge Investments’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-36,808
Closed -$1M – 934
2019
Q4 		$1M Sell
36,808
-27,983
-43% -$770K 0.02% 577
2019
Q3 		$1.85M Buy
64,791
+5,563
+9% +$162K 0.03% 439
2019
Q2 		$1.65M Buy
59,228
+7,800
+15% +$220K 0.03% 428
2019
Q1 		$1.71M Buy
51,428
+33,426
+186% +$1.02M 0.03% 374
2018
Q4 		$524K Buy
18,002
+3,468
+24% +$125K 0.01% 676
2018
Q3 		$668K Buy
14,534
+2,992
+26% +$133K 0.01% 688
2018
Q2 		$432K Sell
11,542
-584
-5% -$19.7K 0.01% 719
2018
Q1 		$358K Sell
12,126
-92,157
-88% -$3.12M 0.01% 752
2017
Q4 		$3.58M Buy
104,283
+10,715
+11% +$361K 0.09% 198
2017
Q3 		$3.38M Buy
93,568
+25
+0% +$713 0.08% 203
2017
Q2 		$2.42M Buy
93,543
+84,661
+953% +$1.8M 0.06% 239
2017
Q1 		$171K Buy
+8,882
New +$157K ﹤0.01% 829
2015
Q1 		– Sell
-3,527
Closed -$120K – 1132
2014
Q4 		$120K Sell
3,527
-7,634
-68% -$271K ﹤0.01% 876
2014
Q3 		$430K Hold
11,161
– – 0.02% 392
2014
Q2 		$434K Sell
11,161
-76,672
-87% -$2.85M 0.02% 343
2014
Q1 		$3M Sell
87,833
-3,086
-3% -$95.6K 0.1% 184
2013
Q4 		$1.91M Buy
90,919
+72,016
+381% +$1.82M 0.06% 254
2013
Q3 		$444K Buy
18,903
+10,192
+117% +$290K 0.01% 373
2013
Q2 		$234K Buy
+8,711
New +$252K 0.01% 456

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PineBridge Investments's MYGN Position: Q1 2020 in Review

PineBridge Investments sold out of Myriad Genetics (MYGN) in Q1 2020, closing a stake of 36,808 shares — an estimated $1M sold.

PineBridge Investments first reported a position in MYGN in Q2 2013 and held it in 19 quarters. The position peaked at $3.58M in Q4 2017. 190 funds tracked by Wall St. Rank hold MYGN as of Q1 2020.

  • PineBridge Investments reported no remaining Myriad Genetics position as of Q1 2020 after selling out during the quarter.
  • PineBridge Investments sold 36,808 Myriad Genetics shares in Q1 2020, an estimated $1M.
  • PineBridge Investments first reported a position in Myriad Genetics in Q2 2013 and held it in 19 quarters.
  • PineBridge Investments's Myriad Genetics position peaked at $3.58M in Q4 2017.
  • 190 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2020.

Based on PineBridge Investments's 13F filing for Q1 2020, filed 14 May 2020.